Thromb Haemost 1970; 17(03): 621-626
DOI: 10.1055/s-0038-1654192
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Effects of Chemical Compounds upon Current Induced Thrombosis in Rat Mesenteric Vessels

R. K Aaron
1   Electrochemical and Biophysical Laboratories of the Vascular Surgical Services, Department of Surgery and Surgical Research, State University of New York, Downstate Medical Center, Brooklyn, New York, 11203
,
S Srinivasan*
1   Electrochemical and Biophysical Laboratories of the Vascular Surgical Services, Department of Surgery and Surgical Research, State University of New York, Downstate Medical Center, Brooklyn, New York, 11203
,
B Burrowbs
1   Electrochemical and Biophysical Laboratories of the Vascular Surgical Services, Department of Surgery and Surgical Research, State University of New York, Downstate Medical Center, Brooklyn, New York, 11203
,
P. N Sawyer
1   Electrochemical and Biophysical Laboratories of the Vascular Surgical Services, Department of Surgery and Surgical Research, State University of New York, Downstate Medical Center, Brooklyn, New York, 11203
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Preview

Summary

From previous work in our laboratories, there is a large amount of evidence for an electrochemical mechanism of thrombosis. The blood vessel wall and blood cells are negatively charged under normal conditions. Antithrombogenic drugs increase their negative charge densities while thrombogenic drugs have the opposite effect. Injury makes the blood vessel wall less negatively charged or even positively charged. There is a relation between vascular injury currents and thrombosis. In the present study, the effect of certain chemical agents upon in situ thrombosis in rat mesoappendix vessels, produced by an applied electric current of the sign and magnitude of physiological injury currents, is examined. Compounds such as polyquarternary, with basic groups enhance thrombosis while compounds such as heparin with acidic groups inhibit thrombosis.

* Recipient of Career Scientist Award, Health Research Council of the City of New York (Contract No. I 542).